Bigul

Tiaan Ayurvedic & Herbs Ltd - 540108 - Statement Of Investor Complaints For The Quarter Ended December 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 8071 Name of the Signatory :- Sudharshan RangarajanDesignation :- Director
17-01-2020
Bigul

Tiaan Ayurvedic & Herbs Ltd - 540108 - Shareholding for the Period Ended December 31, 2019

Tiaan Ayurvedic & Herbs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
17-01-2020
Bigul

Tiaan Ayurvedic & Herbs Ltd - 540108 - Appointment of Company Secretary and Compliance Officer

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company has appointed Mr. Shanoo Mathew (M. No.: A60688), as a Company Secretary & Compliance Officer of the Company pursuant to Section 203 of Companies Act, 2013 and Regulation 6 of SEBI LODR with effect from 31st December, 2019.
01-01-2020
Bigul

Tiaan Ayurvedic & Herbs Ltd - 540108 - Closure of Trading Window

With reference to the captioned matter, this is to inform the exchange that in terms of the Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company will remain closed from 1st January, 2020 till 48 hours after the declaration of the unaudited financial results for the quarter and nine months ended 31st December, 2019.
31-12-2019
Bigul

Tiaan Ayurvedic & Herbs Ltd - 540108 - Announcement under Regulation 30 (LODR)-Resignation of Director

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 we wish to informed that Mr. Imteyaz Shaikh, Executive Director of the Company has tendered his resignation from the Board of the Company.
09-12-2019
Bigul

Tiaan Ayurvedic & Herbs Ltd - 540108 - Clarification

With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Tiaan Ayurvedic & Herbs Ltd has submitted to BSE a copy of Clarification is enclosed.
25-11-2019
Bigul

Tiaan Ayurvedic & Herbs Ltd - 540108 - Clarification sought from Tiaan Ayurvedic & Herbs Ltd

The Exchange has sought clarification from Tiaan Ayurvedic & Herbs Ltd on 22nd November, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
23-11-2019
Bigul

Tiaan Ayurvedic & Herbs Ltd - 540108 - Results - Financial Results For September 30, 2019.

Results - Financial Results for September 30, 2019.
14-11-2019
Bigul

Tiaan Ayurvedic & Herbs Ltd - 540108 - Outcome Of Board Meeting Held On 14.11.2019.

With reference to the above, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. Thursday, 14th November, 2019 inter alia has approved the following business: 1.Standalone Un-audited Financial Results for the Quarter and half year ended on 30th September, 2019 along with Limited Review Report of the above said results for the Quarter and half year ended on 30th September, 2019. 2.Mr. Samadhan Kharate (DIN: 07822456), Independent Director, ceased to be the Director of the Company with effect from 14.11.2019.
14-11-2019
Bigul

Tiaan Ayurvedic & Herbs Ltd - 540108 - Board Meeting Intimation for Consideration And Approval Of Standalone Un-Audited Financial Results For The Quarter And Half Year Ended On 30Th September, 2019.

Tiaan Ayurvedic & Herbs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Standalone Un-audited Financial Results for the Quarter and half year ended on 30th September, 2019.
01-11-2019
Next Page
Close

Let's Open Free Demat Account